techMARK (TASX)

4,498.82
   
  • Change Today:
      37.87
  • 52 Week High: 4,754.14
  • 52 Week Low: 3,951.85

Oxford Biomedica signs new Covid vaccine deal with AstraZeneca

By Frank Prenesti

Date: Friday 01 Jul 2022

LONDON (ShareCast) - (Sharecast News) - Oxford Biomedica has signed a new three-year deal to make AstraZeneca's Covid-19 vaccine beyond this year when the original agreement expires, the company said on Friday.
The Oxford-based gene and cell therapy group said it expected to record about £30m in revenue from the contract in the current financial year.

Under the new deal, manufacturing of vaccines at Oxford manufacturing facility, Oxbox, will be available to AstraZeneca on an as-needed basis beyond 2022.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Price Data

Price 4,498.82
Change Today 37.87
% Change 0.85 %
22-Apr-24 Close 4,460.95

Top Risers

Price Change
FLTR 15,055.00p +2.2%
NCC 127.80p +2.1%
RCDO 469.00p +2.0%
SN. 991.20p +1.7%
GNS 1,752.00p +1.5%
BA. 1,335.00p +1.4%
OXB 215.50p +1.4%
SPT 194.00p +1.1%
SGE 1,153.50p +0.8%
SXS 3,238.00p +0.7%

Top Fallers

Price Change
APTD 302.00p -1.3%
XPP 1,056.00p -0.9%
TRD 253.33p -0.7%
BT.A 107.90p -0.2%
QQ. 342.20p -0.2%

Top of Page